| HPV+ (n = 16) | HPV- (n = 94) | p-value | ||
---|---|---|---|---|---|
 | n | % | n | % | |
Mean age (years) | 59.1 | 59.0 | 0.98 | ||
M:F ratio | 4.3:1 | 6.8:1 | 0.52 | ||
NK morphology | 8 | 44% | 0 | 0% | <  0.001a |
K morphology | 5 | 28% | 79 | 86% | Â |
p16-positive | 15 | 93.75% | 16 | 17% | <  0.001a |
Tonsil | 13 | 81.25% | 24 | 25.53% | <  0.001a |
Alive | 13 | 81.25% | 29 | 30.85% | <  0.001a |
Median survival (months) | 34 | 15 | 0.03a | ||
T1–2 stage | 12 | 75% | 34 | 36.17% | 0.006a |
N1–3 stage | 13 | 81.25% | 66 | 70.21% | 0.55 |
M1 stage | 0 | 0% | 6 | 7% | 0.26 |
Smoking | 8/16 | 50% | 68/85 | 80% | 0.01a |
Alcohol | 8/12 | 67% | 54/74 | 74% | 0.73 |